Patients | Gender | Age | Antibody | Disease duration | Therapy | mRSS | IDF | Digestive tract involvement |
---|---|---|---|---|---|---|---|---|
1 | Male | 49 | ATA | 2 years | None | 36 | 1 | 1 |
2 | Female | 35 | ATA | 4 years | None | 40 | 1 | 1 |
3 | Female | 48 | ATA | 1 year | None | 27 | 1 | 0 |
4 | Female | 49 | ATA | 1 year | None | 35 | 1 | 0 |
5 | Female | 56 | ATA | 3 years | None | 41 | 0 | 1 |
6 | Female | 36 | ATA | 9 months | None | 38 | 1 | 0 |
7 | Female | 60 | ATA | 2 years | None | 22 | 1 | 0 |
8 | Female | 59 | ATA | 5 months | None | 25 | 1 | 0 |
9 | Female | 36 | ATA | 1 year | None | 20 | 0 | 1 |
10 | Male | 27 | ATA | 6 months | None | 29 | 0 | 0 |
11 | Male | 61 | ATA | 3 years | None | 30 | 1 | 1 |
12 | Female | 58 | ATA | 1 year | None | 28 | 1 | 0 |
13 | Female | 55 | ATA | 5 years | None | 32 | 1 | 1 |
14 | Male | 25 | ATA1 | 8 months | None | 15 | 0 | 0 |
15 | Male | 60 | ATA | 4 years | None | 31 | 0 | 1 |